Earlier this month, in Novartis Pharms. Corp., Inc. v. Accord Healthcare, Inc., et al., No. 2021-1070, the Federal Circuit issued a helpful decision concerning the not-often-discussed written ...
“As AI becomes more prevalent in research and development, and as AI systems become more autonomous, some commentators believe that the POSITA for an AI-related invention should instead be an ...
Addressing the issue of negative claim limitations, the US Court of Appeals for the Federal Circuit granted a petition for panel rehearing, vacated its prior decision (authored by now-retired Judge ...
Gen. Hosp. Corp. v. Sienna Biopharmaceuticals, Inc., No. 2017-1012, 2018 (Fed. Cir. May 4, 2018) (Before Moore, Reyna, and Taranto, J.) (Opinion for the court, Moore ...
The burden of drafting patent applications with sufficient support for antibody claims is not likely to lessen any time soon. The courts and the scientific community are in agreement that antibody ...
Nvidia CEO Jensen Huang caused a stir when he declared recently that kids no longer need to learn to code - AI will do that for us. “Over the last 10-15 years, almost everybody who sits on a stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback